Sirnaomics’ siRNA Therapeutic Candidate, STP705, Granted Orphan Drug Designation By US FDA for Treat
Sirnaomics,Inc.,a leading biopharmaceutical company in discovery and development of RNAi therapeutics,announced today that the Office of Orphan Product Development division of the FDA has granted orph···
Sirnaomics412020-02-11
